KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.75 $7.64 Friday, 26th Apr 2024 FATE stock ended at $3.80. This is 1.81% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.47% from a day low at $3.75 to a day high of $3.95.
90 days $3.75 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Jul 12, 2023 $4.98 $5.08 $4.83 $4.94 1 718 371
Jul 11, 2023 $5.04 $5.06 $4.84 $4.86 1 204 281
Jul 10, 2023 $4.80 $5.06 $4.77 $5.04 1 701 353
Jul 07, 2023 $4.68 $4.80 $4.68 $4.77 1 158 070
Jul 06, 2023 $4.77 $4.81 $4.64 $4.67 1 411 134
Jul 05, 2023 $4.83 $4.96 $4.76 $4.86 1 520 538
Jul 03, 2023 $4.76 $4.87 $4.72 $4.82 763 288
Jun 30, 2023 $4.83 $4.84 $4.67 $4.76 1 229 775
Jun 29, 2023 $4.94 $4.94 $4.75 $4.78 1 738 187
Jun 28, 2023 $5.05 $5.05 $4.85 $4.90 1 585 047
Jun 27, 2023 $5.03 $5.13 $4.88 $5.06 1 311 737
Jun 26, 2023 $5.02 $5.13 $4.88 $4.98 2 351 633
Jun 23, 2023 $5.22 $5.22 $4.95 $5.01 3 179 233
Jun 22, 2023 $5.75 $5.75 $5.22 $5.26 3 264 628
Jun 21, 2023 $5.81 $5.82 $5.54 $5.79 1 806 256
Jun 20, 2023 $5.58 $5.90 $5.42 $5.87 2 206 969
Jun 16, 2023 $5.96 $5.96 $5.53 $5.58 8 781 140
Jun 15, 2023 $5.41 $5.96 $5.36 $5.81 2 545 105
Jun 14, 2023 $5.58 $5.62 $5.29 $5.43 2 165 938
Jun 13, 2023 $5.46 $5.70 $5.41 $5.55 2 189 805
Jun 12, 2023 $4.91 $5.44 $4.75 $5.41 4 165 637
Jun 09, 2023 $5.31 $5.36 $4.82 $4.87 2 517 385
Jun 08, 2023 $5.47 $5.47 $5.05 $5.30 2 624 413
Jun 07, 2023 $5.53 $5.59 $5.35 $5.47 1 882 840
Jun 06, 2023 $5.13 $5.56 $5.06 $5.52 1 943 797
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT